Image Credit: STAT News

STAT+: Neurogene and the race to the bottom of gene therapy

Watchdoq November 14, 2024

At Neurogene, the developer of a gene therapy for Rett syndrome, expediency seems to be the priority, @adamfeuerstein writes.